Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 15:2020:9529465.
doi: 10.1155/2020/9529465. eCollection 2020.

Large-Scale Expansion of Human Mesenchymal Stem Cells

Affiliations
Review

Large-Scale Expansion of Human Mesenchymal Stem Cells

Muhammad Najib Fathi Bin Hassan et al. Stem Cells Int. .

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells with strong immunosuppressive property that renders them an attractive source of cells for cell therapy. MSCs have been studied in multiple clinical trials to treat liver diseases, peripheral nerve damage, graft-versus-host disease, autoimmune diseases, diabetes mellitus, and cardiovascular damage. Millions to hundred millions of MSCs are required per patient depending on the disease, route of administration, frequency of administration, and patient body weight. Multiple large-scale cell expansion strategies have been described in the literature to fetch the cell quantity required for the therapy. In this review, bioprocessing strategies for large-scale expansion of MSCs were systematically reviewed and discussed. The literature search in Medline and Scopus databases identified 26 articles that met the inclusion criteria and were included in this review. These articles described the large-scale expansion of 7 different sources of MSCs using 4 different bioprocessing strategies, i.e., bioreactor, spinner flask, roller bottle, and multilayered flask. The bioreactor, spinner flask, and multilayered flask were more commonly used to upscale the MSCs compared to the roller bottle. Generally, a higher expansion ratio was achieved with the bioreactor and multilayered flask. Importantly, regardless of the bioprocessing strategies, the expanded MSCs were able to maintain its phenotype and potency. In summary, the bioreactor, spinner flask, roller bottle, and multilayered flask can be used for large-scale expansion of MSCs without compromising the cell quality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of article selection process.
Figure 2
Figure 2
Frequency of the mesenchymal stem cell (MSC) sources in the selected articles. Most of the studies expanded the MSCs derived from bone marrow, adipose tissue, and Wharton's jelly. BM: bone marrow; AT: adipose tissue; WJ: Wharton's jelly; PD: periosteum; VC: villous chorion; F: fetal; DP: dental pulp.
Figure 3
Figure 3
Frequency of the bioprocessing strategies used in the selected studies. Most of the studies used bioreactor, spinner flask, and multilayered flask for large-scale expansion of MSCs.
Figure 4
Figure 4
Expansion ratios achieved using different bioprocessing strategies. Multilayered flask and bioreactor can achieve higher expansion ratio compared to spinner flask and roller bottle.

References

    1. Hafez P., Chowdhury S. R., Jose S., et al. Development of an in vitro cardiac ischemic model using primary human cardiomyocytes. Cardiovascular Engineering and Technology. 2018;9(3):529–538. doi: 10.1007/s13239-018-0368-8. - DOI - PubMed
    1. Liau L. L., Makpol S., Azurah A. G. N., Chua K. H. Human adipose-derived mesenchymal stem cells promote recovery of injured HepG2 cell line and show sign of early hepatogenic differentiation. Cytotechnology. 2018;70(4):1221–1233. doi: 10.1007/s10616-018-0214-8. - DOI - PMC - PubMed
    1. Lim J., Razi Z. R. M., Law J. X., et al. Mesenchymal stromal cells from the maternal segment of human umbilical cord is ideal for bone regeneration in allogenic setting. Tissue Eng Regen Med. 2018;15(1):75–87. doi: 10.1007/s13770-017-0086-6. - DOI - PMC - PubMed
    1. Lim W. L., Liau L. L., Ng M. H., Shiplu R. C., Law J. X. Current progress in tendon and ligament tissue engineering. Tissue Engineering and Regenerative Medicine. 2019;16(6):549–571. doi: 10.1007/s13770-019-00196-w. - DOI - PMC - PubMed
    1. Liau L. L., Ruszymah B. H. I., Ng M. H., Law J. X. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells. Current Research in Translational Medicine. 2020;68(1):5–16. doi: 10.1016/j.retram.2019.09.001. - DOI - PubMed

LinkOut - more resources